Feasibility Testing of Plant-Based Supplemented Food Products Made With Manitoba Crop Ingredients for Weight Loss
The purpose of this study is to advance the development of the WI/CDIC supplemented foods by evaluating the acceptance and feasibility of the supplemented food bars within the Wellness Institute's Weight Loss Clinic program (WLC) or an equivalent weight loss program in Winnipeg or the surrounding area. The main questions it aims to answer are:
- To determine whether the incorporation of WI/CDIC supplemented foods into the WI weight loss clinic design is feasible.
- To determine whether weight loss is supported by a plant-based supplemented food.
- To assess efficacy of the supplemented food by measuring changes in lifestyle behaviours and risk factors for chronic disease compared to non-supplemented food weight loss program members.
Researchers will compare the WLC program plus supplemented food to the WLC program without the supplemented food to evaluate the implementation of the supplemented foods into the WLC.
Participants will follow their WLC program for the initial 16 weeks, and those in the intervention group will begin their supplemented food. Participants will consume one supplemented food bar each day and will record this in the product consumption log.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This is a pilot evaluation of the feasibility of incorporating the WI/CDIC supplemented food into the WI's newly designed WLC. This study will employ a mixed methods quasi-experimental approach using questionnaires and data collected over the evaluation period. Following consent, participants will be asked to fill out a set of questionnaires, to capture dietary intake, and to wear an activity monitor; to measure diet, physical activity, QOL and sleep before each study meeting. Eligible participants (n=40) will be randomized to intervention (supplemented food) or no intervention. Participants will attend two in-person study visits - one at the initiation and one at the completion of the 16-week weight loss program. Body weight, height, waist circumference, blood pressure and heart rate will be recorded at these two time points as well, as collected through the weight loss clinic program. Participants will also complete an exit questionnaire at the second visit that will include a 9-point hedonic scale to evaluate product acceptability.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Kathy Cherepak, BSc
- Telefonnummer: 204-631-3834
- E-mail: kcherepak@sogh.mb.ca
Undersøgelse Kontakt Backup
- Navn: Dr Dylan MacKay, PhD
- Telefonnummer: 204-272-3119
- E-mail: Dylan.Mackay@umanitoba.ca
Studiesteder
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2V 3M3
- Seven Oaks Hospital Chronic Disease Innovation Centre
-
Kontakt:
- Kathy Cherepak, BSc
- Telefonnummer: 204-631-3834
- E-mail: kcherepak@sogh.mb.ca
-
Underforsker:
- Dr Rebecca Mollard, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female, aged 18 years or above
- Live within the province of MB
- Ability to give written informed consent in English.
- Enrolled in the Wellness Institute Weight Loss Clinic or an equivalent, approved weight loss program in Winnipeg or the surrounding area.
Exclusion Criteria:
- Female participant who is pregnant, lactating or planning pregnancy during the course of the program.
- Participants with known allergies to the supplemented food ingredients
- Has an active eating disorder
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: The WLC program plus supplemented food
Participants in weight loss clinic program will consume one supplemented food bar each day and will record this in the product consumption log. |
These supplemented foods provide plant-based protein, fibre and fatty acids that have been shown to have health benefits related to chronic disease. |
|
Ingen indgriben: The WLC program only
Participants in the weight loss clinic only. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of incorporating the WI/CDIC supplemented foods into the WI weight loss clinic.
Tidsramme: End of Study (Week 16)
|
Feasibility will be demonstrated if the following five criteria are met:
|
End of Study (Week 16)
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Body Weight
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Body weight will be measured in kg to the nearest 0.1 kg by an exercise professional. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Waist Circumference
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Waist circumference in cm will be measured to the nearest 0.1 cm at the umbilicus, between the last rib and iliac crest using a fibreglass tape measured by an exercise professional. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in BMI
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Body Mass Index will be calculated using the formula BMI = kg/m2; where kg is the weight in kilograms and m2 is height in metres squared. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Cardiovascular Assessment
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Using the Framingham Risk Score, cardiovascular risk will be calculated based on age, HDL-C, total cholesterol, systolic blood pressure, smoking status, and diabetes status to determine the participant's 10-year risk of cardiovascular disease and identification of metabolic syndrome. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes is Quality of Life
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Quality of life will be measured through the SF-36 quality of life questionnaire. The SF-36 measures nine areas: physical functioning, role functioning (emotional), role functioning (physical), energy/fatigue, emotional well-being, social functioning, pain, general health, and health change. A higher score indicates greater levels of quality of life. |
At Enrollment (Week 0) and End of Study (Week 16)
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Systolic Blood Pressure
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Systolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Diastolic Blood Pressure
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diastolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Heart Rate
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Heart rate in beats per minute is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Physical Activity
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Measured using the International Physical Activity Questionnaire - Short Form - (IPAQ-S) |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Change in Physical Activity Behaviour Patterns
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Assessed using total active minutes per day as measured by multi-directional accelerometry for 7 days. Participants will be asked to wear the accelerometer at all times. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake Behaviours
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Dietary intake behaviours will be measured through The Mindful Eating Questionnaire. The Mindful Eating Questionnaire recognizing patterns of overeating or eating in response to stress, boredom, or other emotions. Scoring is based on five categories, which include Awareness (being aware of how food looks, tastes and smells); Distraction (focusing on other things while eating); Disinhibition (eating even when full); Emotional Response (eating in response to sadness or stress); and External Cues (eating in response to environmental cues, such as advertising) |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake Behaviours
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Changes in dietary intake behaviours will be measured through the Three Factor Eating Questionnaire which is comprised of 18 items, measuring uncontrolled eating, restrained eating and emotional eating. The higher the score represents more dependency to cognition, stress or emotion the eating patterns. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Number of Meals
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Number of meals will be captured with a meal being defined as food intake greater than 500 kcal. Dietary intake will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Number of Snacks
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Number of snacks will be captured with a meal being defined as food intake less than 500 kcal. Dietary intake will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Energy
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Energy will be measured in kCals and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Protein
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Protein will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Fat
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Fat will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Available Carbohydrates
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Available carbohydrates will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Fibre
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Fibre will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Sleep Patterns
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
An ActiGraph activity monitor will be used to measure sleep quality patterns for 7 days, with participants asked to wear the monitor at all times, including when they sleep. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Total Cholesterol
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in High density lipoprotein cholesterol
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Low density lipoprotein cholesterol
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Triglycerides
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Total Cholesterol and High-Density Lipoprotein Cholesterol Ratio
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Hemoglobin A1C
Tidsramme: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Dr Dylan MacKay, PhD, University of Manitoba
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- HS26095 (B2023:073)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
De-identified individual participant data (IPD) may be placed in a repository if required by a journal for publication purposes. De-identified IPD may also be requested from the principle investigator.
IPD-delingstidsramme
Data will become available following the publication of the primary results manuscript.
IPD-delingsadgangskriterier
Researchers who provide a methodologically sound proposal and whose proposed use of the data has been approved by the trial PI.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .